A new policy brief from Health Affairs and the Robert Wood Johnson Foundation (RWJF) describes the repercussions of antibiotic resistance: when drugs have declining, limited, or no effectiveness in combatting certain bacterial infections. In the United
Read More...
Read the complete post at http://healthaffairs.org/blog/2015/05/22/new-health-policy-brief-antibiotic-resistance/
Posted
May 22 2015, 09:32 AM
by
Health Affairs Blog
Filed under: Public Health, Global Health, Elsewhere@ Health Affairs, Population Health, Drugs and Medical Technology, FDA, Antimicrobial, Antibiotic Resistance, Agriculture, Research and Development, superbugs, Drug approval